The University of Colorado Anschutz Medical Campus (CU Anschutz), HEREDITARY’s only U.S. partner, has published a new article showcasing its contribution to the project and the potential of AI to support the early detection of Parkinson’s disease through retinal imaging.
Within HEREDITARY, researchers at the Sue Anschutz-Rodgers Eye Center are investigating whether AI can identify retinal biomarkers associated with neurodegenerative diseases such as Parkinson’s disease and multiple sclerosis. By combining retinal images with other clinical and biomedical data, the team aims to develop multimodal AI models that could contribute to earlier, less invasive diagnosis.
The article also highlights the role of federated learning, a key approach within HEREDITARY that enables institutions to collaboratively train AI models while keeping sensitive patient data securely at their original locations. This privacy-preserving methodology allows researchers across the consortium to build more robust and reliable models without sharing raw clinical data.
As HEREDITARY’s only U.S.-based partner, CU Anschutz brings internationally recognised expertise in ophthalmic AI, oculomics, and federated learning, strengthening the consortium’s efforts to better understand the gut-brain axis and advance research into neurodegenerative diseases.
Want to learn more about CU Anschutz’s contribution to HEREDITARY? Read the full article on their website. READ NOW!
Recent Comments